Iron-chelating agents affect ferroptosis and diabetes and its complications through the nuclear factor kappa B (NF-κB) signaling pathway, and lncRNAs play a role in the NF-κB signaling pathway of ferroptosis, affecting the occurrence and development of diabetes. This evidence concerns the gene NFKB1 and diabetes mellitus.